HIV

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique.

Pediatric HIV researcher Carlucci discusses work in Mozambique

When James Carlucci, MD, MPH, instructor of Pediatric Infectious Diseases, is in Nashville he treats children at Monroe Carell Jr. Children’s Hospital at Vanderbilt. When he’s on one of the several trips he takes each year to Mozambique, he’s trying to understand when and why HIV-exposed infants fall out of care — and how to change it.

HIV virus

New HIV research training program launched

With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.

HIV virus

A “public” target for HIV

Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.

HIV outreach and return to care

When chronic disease patients let their care lapse and fail to show for clinic appointments, it may behoove clinics to reach out and encourage a return to care.

1 2 3 4